Understanding how to Best Run Clinical Trials in BRIC Countries
BRIC countries are significantly different from each other in terms of capacity, regulatory status, operational skills, site expertise etc. Hence it is important for researchers to look at Brazil, Russia, India and China independently rather than as one homogenous group. In recent years, there have been tremendous developments in terms of regulatory timelines, development of clinical and paramedical staff involved in clinical trials, ethical issues related to patients, compensation etc in each these countries.
Viraj Rajadhyaksha, Director, Medical Affairs (Internal medicine, Tier II and Institutional Business/Corporate Hospitals, Sanofi, India) will address these considerations. In his presentation he will explore ways and means to work successfully in the emerging world.
The Clinical Trials Outsourcing Summit will provide a forum for discussion and networking between senior-level executives from western and eastern pharmaceutical, biotech and CRO organisations.
The forum will cover:
- the future development of, and potential opportunities for clinical trials in Asia
- the current regulatory landscape
- the unique operational challenges associated with countries in the region including:
- CRO management
- data management
- pharmacovigilance & safety
- clinical trial supply logistics
The 2nd Global Clinical Trials Summit takes place in Seoul, South Korea on 20th & 21st May 2013 and is supported by KHIDI – the Korean Health Industry Development. The summit includes a half-day workshop: A Step by Step Approach to Globalize your Biosimilars Product on the 22nd May, 2013.
For more information please visit:
Global Clinical Trials Summit
+44 7944 471246
Suite B, The Kidlington Centre